메뉴 건너뛰기




Volumn 66, Issue 5, 2013, Pages 410-412

Valvular heart disease in hyperprolactinemic patients treated with low doses of cabergoline;Afección valvular cardiaca por dosis bajas de cabergolina en pacientes hiperprolactinémicos

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; ERGOLINE DERIVATIVE;

EID: 84876740177     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2012.10.020     Document Type: Letter
Times cited : (14)

References (6)
  • 2
    • 0034610435 scopus 로고    scopus 로고
    • Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications
    • R.B. Rothman, M.H. Baumann, J.E. Savage, L. Rauser, A. McBride, and S.J. Hufeisen Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications Circulation 102 2000 2836 2841
    • (2000) Circulation , vol.102 , pp. 2836-2841
    • Rothman, R.B.1    Baumann, M.H.2    Savage, J.E.3    Rauser, L.4    McBride, A.5    Hufeisen, S.J.6
  • 5
    • 64749106695 scopus 로고    scopus 로고
    • Dopamine Agonist therapy for Hyperprolactinemia and cardiac valve dysfunction; A lot done but much more to do
    • M. Sherlock, A. Toogood, and R. Steeds Dopamine Agonist therapy for Hyperprolactinemia and cardiac valve dysfunction; a lot done but much more to do Heart 95 2009 522 523
    • (2009) Heart , vol.95 , pp. 522-523
    • Sherlock, M.1    Toogood, A.2    Steeds, R.3
  • 6
    • 79952451066 scopus 로고    scopus 로고
    • Sistema endocrino y corazón: Una revisión
    • S. Rhee, and E. Pearce Sistema endocrino y corazón: una revisión Rev Esp Cardiol 64 2011 220 231
    • (2011) Rev Esp Cardiol , vol.64 , pp. 220-231
    • Rhee, S.1    Pearce, E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.